Pharmacogenomics in hypertension: Present practicalities and future potential

Journal of Hypertension

Volumn 23, Issue 7, 2005, Pages 1327-1329

  Brain, Nick J R ^a   Dominiczak, Anna F ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE THERAPY; EDITORIAL; HEALTH CARE; HUMAN; HYPERTENSION; PHARMACOGENOMICS; PRESCRIPTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME;

EID: 21644464483     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000173511.30116.89     Document Type: Editorial

References (16)

1. Mellen PB, Herrington DM. Pharmacogenomics of blood pressure response to antihypertensive treatment. J Hypertens 2005; 23:1311-1325.
2. McLeod HL, Evans WE. Pharmacogenomics: Unlocking the human genome for better drug therapy. Annu Rev Pharmacol Toxicol 2001; 41:101-121.
3. ESH and E-SC Hypertension Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21:1011-1053.
4. Mancia G, Sega R, Milesi C, Cesana G, Zanchetti A. Blood-pressure control in the hypertensive population. Lancet 1997; 349:454-457.
5. Carretero OA, Oparil S. Essential hypertension part II: treatment. Circulation 2000; 101:446-453.
6. Cadman PE, O'Connor DT. Pharmacogenomics of hypertension. Curr Op Nephrol Hyperten 2003; 12:61-70.
7. Cardon LR, Palmer U. Population stratification and spurious allelic association. Lancet 2003; 361:598-604.
8. Anonymous. Freely associating. Nature 1999; 22:1-2.
9. Tabor HK, Risch NJ, Myers RM. Candidate-gene approaches for studying complex genetic traits: practical considerations. Nat Rev Genet 2002; 3:391-396.
10. Solus JF, Arietta BJ, Harris JR, Sexton DP, Steward JQ, McMunn C, et al. Genetic variation in 11 phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics 2004; 5:895-931.
11. Johnson GCL, Esposito L, Barratt BJ, Smith AN, Heward J, Di Genova G, et al. Haplotype tagging for the identification of common disease genes. Nat Genet 2001; 29:233-237.
12. Ahmadi KR, Weale ME, Xue ZY, Soranzo N, Yarnall DP, Briley JD, et al. A single-nucleotide polymorphism tagging set for human drug metabolism and transport. Nat Genet 2005; 37:84-89.
13. Roses AD. Pharmacogenetics and the practice of medicine. Nature 2000; 405:857-865.
14. Hirschhorn JN, Daly MJ. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 2005; 6:95-108.
15. Xu CF, Lewis KF, Yeo AJ, McCarthy LC, Maguire MF, Anwar Z, et al. Identification of a pharmacogenetic effect by linkage disequilibrium mapping. Pharmacogenomics J 2004; 4:374-378.
16. Haga SB, Burke W. Using pharmacogenetics to improve drug safety and efficacy. JAMA 2004; 291:2869-2871.